Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005865 · ClinicalTrials.gov registry record · Phase 2
Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
A Phase 2 study of Lung Cancer, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Study locations
NCT00005865 is a Phase 2 study of Lung Cancer that has completed, run by GlaxoSmithKline. The trial reports 20 study locations across 11 states.
The verdict
NCT00005865, a Phase 2 study of Lung Cancer, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20
- Study locations
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving drugs in different ways may kill more tumor cells. It is not yet known whether giving vinorelbine by mouth or infusion is more effective in treating non- small cell lung cancer. PURPOSE: Randomized phase II trial to compare the effectiveness of vinorelbine given by mouth or as an infusion in treating patients who have stage IIIB or stage IV non-small cell lung cancer.
Conditions Studied
Interventions
- DRUG vinorelbine tartrate
Study Locations (20)
Michigan
- Barbara Ann Karmanos Cancer Institute - Detroit
- Sparrow Regional Cancer Center - Lansing
- Lakeland Medical Center - St. Joseph - Saint Joseph
- Providence Hospital Cancer Center - Southfield
California
- NorthBay Healthcare System - Fairfield
- Wilshire Oncology Medical Center - Pomona
- Cancer Care Consultants of Northern California - Redding
Arizona
- Arizona Clinical Research Center - Tucson
- Veterans Affairs Medical Center - Tucson - Tucson
Arkansas
- Highlands Oncology Group, P.A. - Fayetteville
- Genesis Cancer Center - Hot Springs
Florida
- Comprehensive Cancer Care Specialists of Boca Raton - Boca Raton
- West Florida Cancer Institute - Pensacola - Pensacola
Louisiana
- Medical Oncology, LLC - Baton Rouge
- Office of Luis Alberto Meza - Lafayette
Illinois
- University of Chicago Cancer Research Center - Chicago
Indiana
- South Bend Clinic and SurgiCenter - South Bend
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-04 |
| Est. Completion | 2007-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00005865
The ClinicalTrials.gov registry entry for NCT00005865 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which vinorelbine tartrate is the first listed.
NCT00005865 reports 20 study locations spanning 11 distinct geographic areas - top geographies include Michigan, California, Arizona.
Frequently Asked Questions
What is clinical trial NCT00005865 about?
NCT00005865 is a clinical study titled "Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving drugs in different ways may kill more tumor cells. It is not yet known whether giving vinorelbine by mouth or infusion is more effective in treating non- small cell lung can...
What is the current status of trial NCT00005865?
This trial is currently completed. It is a Phase 2 study. The study started on 2000-04. Estimated completion is 2007-06.
What conditions does trial NCT00005865 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT00005865?
The interventions under investigation include: vinorelbine tartrate (DRUG).
Who is sponsoring clinical trial NCT00005865?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00005865 being conducted?
This trial has 20 study locations across Arizona, Arkansas, California, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of Novel Treatment Combinations in Patients With Lung Cancer
RECRUITING · Phase 2
-
Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®
RECRUITING · Phase 2
-
ATATcH Alternating Treatment Plans for Advanced Cancer
RECRUITING · Phase 2
-
A Phase II Study of Neoadjuvant Sotorasib in Combination With Cisplatin or Carboplatin and Pemetrexed for Surgically Resectable Stage IIA-IIIB Non-Squamous Non-Small Cell Lung Cancer With a KRAS p.G12C Mutation
RECRUITING · Phase 2
-
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
RECRUITING · Phase 2
-
Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.